Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07011459 · ClinicalTrials.gov registry record · NA

The Cooking for Health Optimization and Disease Prevention (CHOP) Trial

A NA study of Cardiovascular Diseases, sponsored by Tulane University.

Recruiting
Registry status
NA
Development phase
96
Enrollment target
2
Study locations

NCT07011459: Recruiting NA study of Cardiovascular Diseases, sponsored by Tulane University.

NCT07011459 is a NA study of Cardiovascular Diseases that is actively recruiting participants, run by Tulane University. The registered enrollment target is 96 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07011459, a NA study of Cardiovascular Diseases, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target
2
Study locations

Study Summary

Poor nutrition-related diseases disproportionately impact seniors and racial/ethnic minorities who are more likely to experience disparities in proper nutrition. Culinary medicine is a new evidence-based educational approach that blends the art of food and cooking with the science of medicine. Recently, culinary medicine is proposed by the 2020-2030 Strategic Plan for NIH Nutrition Research and national 'Food is Medicine (FIM)' Movement as potential solutions for improving healthy eating, creating social and emotional connections, and nutrition-related health equity. Built upon the well-established community teaching kitchen at The Goldring Center for Culinary Medicine (GCCM) at Tulane University and nearly 10 years of experience in delivering culinary education of Mediterranean diet (MedDiet), the investigators will conduct a randomized controlled trial (RCT) to test the feasibility and effectiveness of 3-month community teaching kitchen-based culinary education of MedDiet on improving cardiometabolic and mental health among racially and ethnically diverse seniors.

Primary Outcome

The investigators will measure the change in blood pressure from baseline visit 1 to visit 3. The average of 3 blood pressure readings will be taken. They will be measured at baseline visit and at 3 months visit.

Conditions Studied

Interventions

  • OTHER Standard of care
  • BEHAVIORAL Cooking class

Study Locations (2)

Louisiana

  • The Goldring Center for Culinary Medicine - New Orleans
  • Tulane Weatherhead School of Public Health and Tropical Medicine - New Orleans

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2025-07-07
Est. Completion 2026-12
Phase NA
Tulane University

73 total trials

What NCT07011459 shows while recruiting

NCT07011459 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT07011459 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT07011459 about?

NCT07011459 is a clinical study titled "The Cooking for Health Optimization and Disease Prevention (CHOP) Trial". Poor nutrition-related diseases disproportionately impact seniors and racial/ethnic minorities who are more likely to experience disparities in proper nutrition. Culinary medicine is a new evidence-based educational approach that blends the art of food and cooking with the science of medicine. Recen...

What is the current status of trial NCT07011459?

This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2025-07-07. Estimated completion is 2026-12.

What conditions does trial NCT07011459 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT07011459?

The interventions under investigation include: Standard of care (OTHER), Cooking class (BEHAVIORAL).

Who is sponsoring clinical trial NCT07011459?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07011459 being conducted?

This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07011459's enrollment target sits among peer trials

96 201st of 300 higher than 100 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07011459, the US trial registry maintained by the National Library of Medicine. NCT07011459 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.